Cellectis S.A.
ENXTPAALCLS utilization hits 92.96%, near its 52-week peak of 97.95%. Cost to borrow surges to 320.65%, up 15.6% in one week.
Snapshot as of 9 May 2026
No long-form analysis yet for ALCLS. Pulse alerts and the live data picture are available on ORTEX.
Open ALCLS on ORTEX →Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ALCLS — free to start on ORTEX.
Sign up for free →Open ALCLS on ORTEX